News Daily News Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say Michael O'Riordan April 09, 2018
News Daily News Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II Michael O'Riordan February 21, 2018
News Daily News Roughly Half of Obese Patients Who Have Bariatric Surgery Are Off Type 2 Diabetes Meds at 6 Years Michael O'Riordan February 19, 2018
News Daily News No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis Michael O'Riordan February 02, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors Michael O'Riordan December 12, 2017
News Daily News More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA Michael O'Riordan October 24, 2017
News Daily News Secondary Prevention Lagging Behind in Women With Established Coronary Disease Todd Neale September 22, 2017
News Daily News Ischemic Heart Disease the Leading Cause of Death Globally Michael O'Riordan September 19, 2017
Presentation ESC 2017 Impact of BMI on Clinical Outcomes and Readmissions After Cardiac Catheterization Presenter: Afnan Tariq August 26, 2017
News Conference News ESC 2017 Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI Shelley Wood August 26, 2017
News Daily News Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards Shelley Wood February 28, 2017
News Daily News HDL Function Improved With Olive Oil-Enriched Mediterranean Diet: PREDIMED Study Michael O'Riordan February 14, 2017
News Daily News Younger Adults With Severe Dyslipidemia Less Likely to Be Prescribed Statins Michael O'Riordan January 05, 2017
News Daily News Lipid Losses: National Data Show Drastic Drops in Total Cholesterol, Triglycerides, and LDL Yael L. Maxwell November 30, 2016
News Daily News Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes Michael O'Riordan August 12, 2016